Full Genomes Corp
Other Technology · Rockville, Maryland
Full Genomes Corp is a other technology company based in Rockville, Maryland, incorporated in 2013. It has raised at least $612,077 across 7 known rounds, of which $352,077 was reported to the SEC on 7 Form D filings, most recently in 2019.
| Date | Round | Amount | Raised to date | Lead investor | Source |
|---|---|---|---|---|---|
| 2019-03-11 | — | $25K | $612K | SEC Form D | |
| 2018-08-27 | — | $188K | $587K | SEC Form D | |
| 2017-11-01 | —+1 amd | $100K | $399K | SEC Form D | |
| 2016-05-09 | — | $19K | $299K | SEC Form D | |
| 2015-10-26 | — | $10K | $280K | SEC Form D | |
| 2015-09-14 | — | $10K | $270K | SEC Form D | |
| 2014-12-09 | — | $10K | $260K | SEC Form D | |
| 2013-09-17 | — | $250K | $250K | SEC Form D |
SEC rows are Form D filings, where the amount is what was actually sold and amendments update a round rather than adding one. Press rows are split between company-issued releases or wires and editorial or third-party coverage. The total is therefore a floor: a round nobody reported is a round we cannot see. A buyout or control change appears in the timeline but is never added to the total: that money goes to shareholders, not into the company.
Form D is the notice a company files with the SEC when it sells securities without registering them. It reports the amount sold, not a valuation. Figures here are what the filing says. Where a filing is silent, the field is left blank rather than estimated. “Total raised” adds press-reported rounds that never appear in a filing, so it is a floor rather than an audited sum: press amounts are the figures the company announced, and a round nobody reported is a round we cannot see.